BIO-EUROPE SPRING 2022®, Suntrap will participate as promised
(Company Newsletter) From March 28 to March 31, 2022, BIO-Europe Spring® is about to open. The exhibition focuses on innovation and global cooperation in the European biotechnology field. It is one of the most cutting-edge international biotechnology industry exhibitions this year. The exhibition has also become a weather vane for the future development of biotechnology. BIO-Europe Spring attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams. According to statistics, more than 1,300 companies from 49 different countries and regions will participate in the exhibition this year, including many leading biopharmaceutical companies, such as Novartis Group, Roche Group, Johnson & Johnson, Sanofi Group, etc.
Overview of 2022 Participating Companies
Agenda of BIO-EUROPE SPRING 2022®
The purpose of Suntrap Life Technologies Ltd. to participate in this event is to show the results of the self-developed broad-spectrum anti-COVID-19 series of preventive and therapeutic drugs to the world. At the same time, we will seek more international cooperation for the research and development of respiratory system diseases, delaying and reversing tissue fibrosis, anti-aging, nervous system diseases, and anti-tumor drugs.